Javascript must be enabled to continue!
Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin® H cream) and miconazole/hydrocortisone cream (Daktacort® cream) in infected eczema
View through CrossRef
AbstractAimTo study the efficacy, tolerability and acceptability of 2% fusidic acid and 1% hydrocortisone with 2% miconazole and 1% hydrocortisone.SubjectAtopic dermatitis and topical therapy with antibacterial/antiinflammatory or antifungal/antiinflammatory remedies.MethodsA randomised, open, parallel group comparison.Results207 patients with clinically infected eczema were included in a trial with either 2% fusidic acid and 1% hydrocortisone or 2% miconazole and 1% hydrocortisone. At the end of treatment, there was no statistically significant difference between treatments in the preparations of patients “cleared” or “markedly improved” (fusidic acid 69.5%, miconazole 68.6%).After 1 week treatment, there was a statistically significant difference in the overall treatment response in favour of fusidic acid/hydrocortisone cream (P = 0.04). Fusidic acid/hydrocortisone cream was significantly more effective than miconazole/hydrocortisone cream at 1 week in reducing the total sign score (P = 0.001), erythema (P = 0.002), induration (P = 0.001), dryness/scaling (P = 0.02). and cracking/fissuring (P = 0.01). Fusidic acid/hydrocortisone cream was significantly more effective bacleriologically than miconazole/hydrocortisone cream (P = 0.04), Patients considered that treatment‐related irritation was significantly more common with fusidic acid/hydrocortisone cream (P = 0.03).Adverse events were recorded in 7 (7.3%) patients given fusidic acid/hydrocortisone and in 8 (7.5%) patients given miconazole/hydrocortisone cream and contributed to treatment withdrawal in 1 (1.0%) patient given fusidic acid/hydrocortisone cream and in 3 (2.8%) patients given miconazole/hydrocortisone cream.ConclusionFusidic acid/hydrocortisone cream and miconazole/hydrocortisone cream were equally effective in treating clinically infected eczema. However, fusidic acid/hydrocortisone cream produced a significantly more rapid clinical improvement and was more effective bacteriologically. Both treatments were well tolerated.
Title: Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin® H cream) and miconazole/hydrocortisone cream (Daktacort® cream) in infected eczema
Description:
AbstractAimTo study the efficacy, tolerability and acceptability of 2% fusidic acid and 1% hydrocortisone with 2% miconazole and 1% hydrocortisone.
SubjectAtopic dermatitis and topical therapy with antibacterial/antiinflammatory or antifungal/antiinflammatory remedies.
MethodsA randomised, open, parallel group comparison.
Results207 patients with clinically infected eczema were included in a trial with either 2% fusidic acid and 1% hydrocortisone or 2% miconazole and 1% hydrocortisone.
At the end of treatment, there was no statistically significant difference between treatments in the preparations of patients “cleared” or “markedly improved” (fusidic acid 69.
5%, miconazole 68.
6%).
After 1 week treatment, there was a statistically significant difference in the overall treatment response in favour of fusidic acid/hydrocortisone cream (P = 0.
04).
Fusidic acid/hydrocortisone cream was significantly more effective than miconazole/hydrocortisone cream at 1 week in reducing the total sign score (P = 0.
001), erythema (P = 0.
002), induration (P = 0.
001), dryness/scaling (P = 0.
02).
and cracking/fissuring (P = 0.
01).
Fusidic acid/hydrocortisone cream was significantly more effective bacleriologically than miconazole/hydrocortisone cream (P = 0.
04), Patients considered that treatment‐related irritation was significantly more common with fusidic acid/hydrocortisone cream (P = 0.
03).
Adverse events were recorded in 7 (7.
3%) patients given fusidic acid/hydrocortisone and in 8 (7.
5%) patients given miconazole/hydrocortisone cream and contributed to treatment withdrawal in 1 (1.
0%) patient given fusidic acid/hydrocortisone cream and in 3 (2.
8%) patients given miconazole/hydrocortisone cream.
ConclusionFusidic acid/hydrocortisone cream and miconazole/hydrocortisone cream were equally effective in treating clinically infected eczema.
However, fusidic acid/hydrocortisone cream produced a significantly more rapid clinical improvement and was more effective bacteriologically.
Both treatments were well tolerated.
Related Results
A Double-Blind Study Comparing Daktacort®, Miconazole and Hydrocortisone in Inflammatory Skin Infections
A Double-Blind Study Comparing Daktacort®, Miconazole and Hydrocortisone in Inflammatory Skin Infections
In a 4-week double-blind trial, Daktacort® cream was compared with each of its constituents (i.e. miconazole 2% and hydrocortisone 1%) in a total of 63 patients (aged 12–60 years) ...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Antifungi Pattern of Candida Species Isolated From the Children Diapers in Obafemi Awolowo University Teaching Hospital Complex, Nigeria
Antifungi Pattern of Candida Species Isolated From the Children Diapers in Obafemi Awolowo University Teaching Hospital Complex, Nigeria
Candidiasis is by far the most common type of yeast infection, these fungi live on all surfaces of our bodies, under certain conditions, they can become so numerous to cause infect...
A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children
A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children
Background: Atopic dermatitis (AD) aetiology is not exactly identified, but it is characterized by pruritic skin reactions with elevation in the levels of inflammatory markers. Des...
Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
Aim of the study: Hydrocortisone is a soft steroid with low
anti-inflammatory properties and a short duration of action, used to
manage several ocular conditions. The clinical bene...
Sideroblastic anaemia during fusidic acid treatment
Sideroblastic anaemia during fusidic acid treatment
Abstract:Objectives and Methods: To describe cases of fusidic acid‐associated sideroblastic anaemia from the French Pharmacovigilance database.Results: Six cases of sideroblastic...
Topical Hydrocortisone Use in the Outpatient Department
Topical Hydrocortisone Use in the Outpatient Department
Aim: This study aimed to describe the use of topical hydrocortisone in the outpatient department in Alkharj.
Methodology: This was a retrospective study that included reviewi...
Association of psoriasis with allergic multimorbidity of asthma, rhinitis, and eczema among adolescents: a cross-sectional study
Association of psoriasis with allergic multimorbidity of asthma, rhinitis, and eczema among adolescents: a cross-sectional study
Abstract
Background
Associations between psoriasis and allergic diseases (asthma, rhinitis, and eczema) in children have been reported in a limited ...

